Edition:
United Kingdom

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

48.90USD
21 Sep 2018
Change (% chg)

-- (--)
Prev Close
$48.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
220,518
52-wk High
$61.25
52-wk Low
$33.45

Latest Key Developments (Source: Significant Developments)

Supernus announces third quarter 2017 financial results
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Supernus Pharmaceuticals Inc :Supernus announces third quarter 2017 financial results.Q3 earnings per share $0.29.Q3 earnings per share view $0.27 -- Thomson Reuters I/B/E/S.Sees full year 2017 net product sales guidance range to $290 million to $295 million​.Sees ‍FY 2017 operating income in range of $85 million to $90 million​.  Full Article

BRIEF-Supernus Pharma Reports Q1 Earnings Per Share $0.49

* SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE